Vancomycin continuous infusion as prophylaxis for vascular surgery

Therapeutic Drug Monitoring

Volumn 31, Issue 6, 2009, Pages 786-788

  Payne, Christopher J ^a   Carmichael, Samantha J ^b   Stearns, Adam T ^a   Kingsmore, David B ^a   Byrne, Dominique S ^c   Binning, Alexander R ^b  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c NONE

Author keywords

Continuous infusion; Prophylaxis; Vancomycin; Vascular surgery

Indexed keywords

VANCOMYCIN;

ADULT; AGED; ANESTHESIA INDUCTION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTINUOUS INFUSION; CREATININE CLEARANCE; FEMALE; HUMAN; INFECTION PREVENTION; LOADING DRUG DOSE; MALE; PRIORITY JOURNAL; SURGICAL INFECTION; VASCULAR SURGERY;

AGED; AGED, 80 AND OVER; ALGORITHMS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MEDICAL AUDIT; MIDDLE AGED; PERIOPERATIVE CARE; PROSTHESIS-RELATED INFECTIONS; TIME FACTORS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 73849133996     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181bddf70     Document Type: Article

References (19)

1. Chambers S. Diagnosis and management of staphylococcal infections of vascular grafts and stents. Intern Med J. 2005;35(Suppl 2):S72-S78. (Pubitemid 44933541)
2. Santini C, Baiocchi P, Serra P. Perioperative antibiotic prophylaxis in vascular surgery. Eur J Vasc Endovasc Surg. 1997;14(Suppl A):13-14.
3. Henke PK, Bergamini TM, Rose SM, et al. Current options in prosthetic vascular graft infection. Am Surg. 1998;64:39-45.
4. Maki DG, Bohn MJ, Stolz SM, et al. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial. J Thorac Car-diovasc Surg. 1992;104:1423-1434.
5. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg. 2005;189:395-404.
6. Carmichael SJ, Thomson AH, Binning AR. Development and audit of dosage guidelines for vancomycin administration by continuous IV infusion. Presented at: The 8th Congress of the International Association of Therapeutic Drug Monitoring & Clinical Toxicology; Basel, Switzerland: September 11, 2003.
7. Binning AR, Buttigieg M, Carmichael SJ, et al. Is it better to infuse vancomycin continuously? Intensive Care Med. 2004;29(Suppl):S79-S122.
8. Wysocki M, Delatour F, Faurisson F, et al. Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother. 2001;45: 2460-2467.
9. Matzke GR, McGory RW, Halstenson CE, et al. Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother. 1984;25:433-437.
10. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
11. Ross CB, Wheeler WG, Jones MJ, et al. Ceftriaxone versus cefazolin in peripheral arterial operations: a randomized, prospective trial. South Med J. 1997;90:16-22.
12. Kester RC, Antrum R, Thornton CA, et al. A comparison of teicoplanin versus cephradine plus metronidazole in the prophylaxis of post-operative infection in vascular surgery. J Hosp Infect. 1999;41:233-243.
13. Nasim A, Thompson MM, Naylor AR, et al. The impact of MRSA on vascular surgery. Eur J Vasc Endovasc Surg. 2001;22:211-214.
14. Kitzes-Cohen R, Farin D, Piva G, et al. Pharmacokinetics of vancomycin administered as prophylaxis before cardiac surgery. Ther Drug Monit. 2000;22:661-667.
15. Ortega GM, Marti-Bonmati E, Guevara SJ, et al. Alteration of vancomycin pharmacokinetics during cardiopulmonary bypass in patients undergoing cardiac surgery. Am J Health Syst Pharm. 2003;60:260-265.
16. Lowdin E, Odenholt I, Cars O. In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylo-coccus epidermidis. Antimicrob Agents Chemother. 1998;42:2739-2744.
17. James JK, Palmer SM, Levine DP, et al. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections. Antimicrob Agents Chemother. 1996;40:696-700.
18. Craig WA. Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am. 2003;17:479-501.
19. Moise-Broder PA, Forrest A, Birmingham MC, et al. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet. 2004;43: 925-942.